Roivant Sciences Limited
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Roivant Sciences Limited
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
/ 
Frequently asked questions
To buy Roivant Sciences Limited stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Roivant Sciences Limited by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Roivant Sciences Limited is ROIV:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Roivant Sciences Limited has its primary listing on NASDAQ. You can trade Roivant Sciences Limited with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Roivant Sciences Limited is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Roivant Sciences Limited as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Roivant Sciences Limited.